Download PDF
Thromb Haemost 1977; 37(01): 136-143
DOI: 10.1055/s-0038-1649211
Original Article
Schattauer GmbH

Immunoelectrophoretic Studies on the Kinetics of Plasmic Degradation of Human Fibrinogen[*]

Roberto Braude
1   Departamento de Docencia e Investigación (Head: Dr. Raúl Altman) Hospital U.A.M.I.-Rivadavia-Peralta Ramos
,
Raúl Altman
1   Departamento de Docencia e Investigación (Head: Dr. Raúl Altman) Hospital U.A.M.I.-Rivadavia-Peralta Ramos
,
Jorge Rouvier
1   Departamento de Docencia e Investigación (Head: Dr. Raúl Altman) Hospital U.A.M.I.-Rivadavia-Peralta Ramos
,
Nélida Aguilar
1   Departamento de Docencia e Investigación (Head: Dr. Raúl Altman) Hospital U.A.M.I.-Rivadavia-Peralta Ramos
› Author Affiliations
Further Information

Publication History

Received 06 November 1975

Accepted 20 July 1976

Publication Date:
03 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

In vitro degradation of fibrinogen results in the appearance of an early fragment, different in its electrophoretic mobility to that of fragments X, Y, D and E.

It reacts with antifibrinogen antiserum, does not react with anti-D antiserum and it is anti-genically related to fragment E.

Compared with terminal fragment E, it migrates more slowly towards the anode, it appears earlier and in a greater concentration at the beginning, decreasing and disappearing during degradation.

The antigen antibody crossed electrophoresis was used in these experiments, but to distinguish the fragments from already known X, Y or even fibrinogen, the applying of an intermediate gel with anti D was of great value.

* Presented in part at the Vth Congress of the International Society on Thrombosis and Haemostasis, Paris 1975.


 

  • References

  • 1 Axelsen N. Crossed electrophoresis with intermediate gel. XlXth. Annual Colloquium of Pro-tides of Biological Fluids. Actas, Chapter XII. Brugge 1971
    PubMedGoogle Scholar
  • 2 Barnhart M.I, Anderson G.F, Baker W.J. Immunochemical studies on protein important in blood coagulation. Thrombosis et Diathesis Haemorrhagica 1962; 8: 21
    PubMedGoogle Scholar
  • 3 Budzynski A.Z, Marder V.J, Shainoff J.R. Structure of plasmic degradation products of human fibrinogen. Fibrinopeptide and polypeptide chain analysis. The Journal of Biological Chemistry 1974; 249: 2294
    PubMedGoogle Scholar
  • 4 Casillas G, Simonetti C, Pavlovsky A. Fibrinogen preparation a partir du complexe fibrinogen-tanin. Revue Francaise d’Etude Cliniques et Biologiques 1960; 5: 925
    PubMedGoogle Scholar
  • 5 Casillas G, Simonetti C, Pavlovsky A. Fractionation of fibrinogen and factor VIII by means of a sulphonamid derivative. Coagulation 1969; 2: 141
    PubMedGoogle Scholar
  • 6 Clark H.G.M, Freeman T. Cuantitative immunoelectrophoresis of human serum proteins. Clinical Science 1968; 35: 403
    PubMedGoogle Scholar
  • 7 Gormsen J, Feddersen C, Clemensen I, Andersen R.B. Degradation of fibrinogen in vitro. Demonstration of several antigenic intermediates by specific anti-D and anti-E serum. Scandinavian Journal of Haematology 1972; 9: 577
    PubMedGoogle Scholar
  • 8 Grabar P, Burtin P. Immunoelectrophoresis Analysis. Elsevier Publications; New York: 1964
    Google Scholar
  • 9 Hawiger J, Niewiarowski S, Gurevich V, Thomas D.P. Measurement of fibrinogen and fibrin degradation products in serum by staphylococal clumping test. The Journal of Laboratory and Clinical Medicine 1970; 75: 93
    PubMedGoogle Scholar
  • 10 Lahiri B, Shafnoff J.R. Fate of fibrinopeptides in the reaction between plasmin and fibrinogen. Biochimica et Biophysica Acta 1973; 303: 161
    CrossrefPubMedGoogle Scholar
  • 11 Laurell C.B. Antigen-antibody Crossed Electrophoresis. Analytical Biochemistry 1965; 1: 358
    PubMedGoogle Scholar
  • 12 Marder V.J, Shulman N.R, Caroll W.R. The importance of intermediate degradation products of fibrinogen in fibrinolytic hemorrhage. Trans. Ass. Am. Phys 1967; 80: 156
    PubMedGoogle Scholar
  • 13 Marder V.J, Shulman N.R, Caroll W.R. High molecular weight derivatives of human fibrinogen produced by plasmin. I. Physicochemical and Immunological Characterization. The Journal of Biological Chemistry 1969; 244: 2111
    PubMedGoogle Scholar
  • 14 Marder V.J. Identification and purification of fibrinogen degradation products prodeced plasmin: considerations on the structure of fibrinogen. Scandinavian Journal of Haematology. Supplement No 1971; (13) 21
    PubMedGoogle Scholar
  • 15 Mills D, Karpatkin S. Heterogenetic of human fibrinog: possible relation to proteolysis by thrombin and plasmin as studied by SDS Polyacrylamide gel electrophoresis. Biochemical and Biophysical Research Dommunication 1970; 40: 206
    PubMedGoogle Scholar
  • 16 Niewiarowsky S, Nandi N. Acrylamide gel electrophophoresis of fibrinogen and fibrin degradation products. British Journal of Haematology 1972; 9: 577
    PubMedGoogle Scholar
  • 17 Nussenzweig V, Seligman M. Analyse, par des méthodes immunochimiques, de la degradation par la plasmine du fibrinogene humain et de la fibrine, a different stades. Revue Hematologie 1960; 15: 451
    PubMedGoogle Scholar
  • 18 Pitcher P.M. Crossed Immunoelectrophoresis for the identification of fibrinogen degradation products. Scandinavian Journal of Haematology. Supplement No 1971; 13: 229
    PubMedGoogle Scholar
  • 19 Scheidegger J.J. Une microméthode d’immunoelectrophorese. Internal Archives of Allergy 1955; 7: 103
    PubMedGoogle Scholar
  • 20 Vermylen J. Fibrinogen derivatives. A Laboratory and Clinical Study. Verhandelingen Van de Koninkluijke. Vlaamse Academie Voör Geneeskunde Van Belgie 1972; 2: 132
    PubMedGoogle Scholar
  • 21 Weeke B. Laurell antigen-antibody crossed electrophoresis. XlXth Annual Colloquium of Pro-tides of Biological Fluids. Actas. Chapter VII. Brugge 1971
    PubMedGoogle Scholar